AI System Can Improve Detection of Congenital Heart Defects In Utero
By Elana Gotkine HealthDay Reporter
TUESDAY, Feb. 4, 2025 -- Artificial intelligence (AI) can improve detection of congenital heart defects (CHDs) on routine prenatal ultrasounds, according to a study presented at The Pregnancy Meeting, the annual meeting of the Society for Maternal-Fetal Medicine, held from Jan. 27 to Feb. 1 in Denver.
Jennifer Lam-Rachlin, M.D., from the Icahn School of Medicine at Mount Sinai Hospital in New York City, and colleagues examined whether an AI system can improve detection of CHDs on fetal ultrasound exams among general obstetricians and gynecologists (OB-GYNs) and maternal-fetal medicine (MFMs) subspecialists. The AI system analyzed grayscale two-dimensional ultrasound cines of an exam and detected eight morphological findings associated with severe CHDs; the presence of any finding was sufficient to refer the patient for further examination. A dataset of 200 ultrasound exams from 11 centers was obtained; 100 exams had suspicious findings. Fourteen physicians (OB-GYNS and MFMs) reviewed each exam aided and unaided by the AI system in randomized order.
The researchers found that the receiver operating characteristic area under the curve for detection of any finding was significantly higher for AI-aided versus unaided reviews (0.97 versus 0.83). The results were similar for sensitivity (0.94 versus 0.78) and specificity (0.97 versus 0.76). The mean reading time was shorter for AI-aided versus unaided review (226 ± 218 versus 274 ± 241 seconds).
"Our findings show that the AI-based software significantly improved detection of ultrasounds that were suspicious for congenital heart defects not only among OB-GYNs but also among maternal-fetal medicine subspecialists," Lam-Rachlin said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Risk for Death From Prostate Cancer Low With Guideline Care for Nonmetastatic Disease
MONDAY, July 14, 2025 -- Men with nonmetastatic prostate cancer receiving guideline-concordant care have a much higher risk for death from causes other than prostate cancer...
AI Support Improves Breast Cancer Detection Accuracy in Mammography
MONDAY, July 14, 2025 -- Artificial intelligence (AI) support improves radiologists' breast cancer detection accuracy when reading mammograms, according to a study published...
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.